![](https://www.businessmarketinsights.com/assets/img/reports-icon.png)
2028년까지 중동 및 아프리카 혈뇨 치료 시장 전망 – 코로나19 영향 및 치료(약물, 치료법 및 기타), 적응증(요로 감염, 신장 결석, 요도염, 혈액암, 방광 결석, 전립선암, 방광염)별 지역 분석 , 외상, 격렬한 운동, 다낭성 신장 질환, 자궁내막증 및 월경), 유형(육안적 혈뇨, 현미경적 혈뇨, 특발성 혈뇨 및 조깅하는 사람의 혈뇨), 최종 사용자(병원, 진료소, 외래 수술 센터 등)
시장 소개
혈뇨는 소변에서 혈액이 발견되는 질병입니다. . 일반적으로 소변에는 적혈구가 포함되어 있지 않으므로 신장 결석, 요로 감염 및 기타 유전 질환을 유발할 수 있는 심각한 문제를 일으킬 수 있습니다.
게다가, 유병률이 높은 혈뇨 관련 징후는 예측 기간 동안 시장 성장을 강화할 것으로 예상됩니다. 그러나 관련 적응증의 진단되지 않은 사례는 중동 및 지역의 성장을 제한합니다. 아프리카 혈뇨 치료 시장.
MEA 지역에서는 중환자실(ICU)에 입원한 환자 수가 증가하고 처방된 의약품 수가 늘어나면서 많은 진단이 창출되고 있습니다. 이미 과중한 의료 시스템에 대한 치료 문제. COVID-19 증상은 대부분 폐기계에서 나타나지만, 비뇨생식기 증상 및/또는 결과에는 특별한 주의가 필요합니다. 심각한 감염 위험은 노인 CKD 환자에서 더 높으며 AKI는 높은 사망률과 관련이 있습니다. 따라서 중증 코로나19 환자의 신장 기능을 모니터링하는 것이 필요했고, 중증 환자의 신장 기능 보호와 사이토카인 제거를 위한 CRRT는 회복 개선에 매우 중요했다. 반면에 코로나19 감염은 비뇨생식기에 영향을 미치는 것으로 보입니다. 코로나19를 치료할 때 비뇨생식기 기관을 고려해야 합니다.
시장 개요 및 역학
중동 & 아프리카 혈뇨치료제 시장은 2021년 4,200만 달러에서 2028년 4,680만 달러에 이를 것으로 예상된다. 2021년부터 2028년까지 CAGR 1.5%로 성장할 것으로 예상됩니다. 만성 신장 질환(CKD)은 더 많은 인구에게 영향을 미치는 흔하고 생명을 위협하는 질환입니다. 신장 결석, 사구체신염, 다낭성 신장 질환, 요로 감염 등 다양한 유형의 CKD가 있습니다. CKD는 혈뇨 발병의 주요 원인 중 하나입니다. 또한 65세 이상 여성의 요로감염 유병률은 전체 인구의 약 11%에 비해 약 20% 수준이다. 현재 중동 및 아프리카 혈뇨 치료 시장은 관련 적응증의 확산으로 크게 성장하고 있습니다.
주요 시장 부문
유형별로는 거시적 혈뇨 부문이 중동 및 아시아 지역에서 가장 큰 비중을 차지했습니다. 2020년 아프리카 혈뇨 치료제 시장. 치료 측면에서 보면 의약품 부문이 중동& 2020년 아프리카 혈뇨치료제 시장. 적응증으로 보면 요로감염 부문이 중동& 2020년 아프리카 혈뇨 치료 시장. 최종 사용자 측면에서 병원 부문은 중동 및 지역에서 가장 큰 점유율을 차지했습니다. 2020년 아프리카 혈뇨 치료 시장.
주요 출처 및 회사 목록
중동 및 지역의 혈뇨 치료 시장에 대한 이 보고서를 준비하는 데 참고된 몇 가지 주요 1차 및 2차 소스입니다. 아프리카에는 회사 웹사이트, 연례 보고서, 재무 보고서, 국가 정부 문서, 통계 데이터베이스 등이 있습니다. 보고서에 나열된 주요 회사는 AstraZeneca, Bristol-Myers Squibb Company, F. HOFFMANN-LA ROCHE LTD., GlaxoSmithKline plc., Janssen Pharmaceuticals, Merck & Co., Inc., Novartis AG, Pfizer Inc., Sun Pharmaceutical Industries Ltd 및 Boehringer Ingelheim International GmbH.
구매 이유 보고서
- 중동 & 아프리카 혈뇨증 치료 시장 환경 및 강력한 수익을 보장할 수 있는 시장 부문 식별
- 끊임없이 변화하는 시장 환경을 이해하고 경쟁에서 앞서 나가기 위해
- 중동 지역에서 인수합병, 파트너십 거래를 효율적으로 계획합니다. 가장 유망한 판매 가능성이 있는 세그먼트를 식별하여 아프리카 혈뇨 치료 시장
- 다양한 세그먼트의 시장 성과에 대한 통찰력 있고 포괄적인 분석을 통해 지식이 풍부한 비즈니스 결정을 내립니다.
- 중동 지역 시장 수익 예측을 얻기 위해 & 2021~2028년 기간의 다양한 부문을 기반으로 하는 아프리카 혈뇨 치료 시장
중동 및amp; 아프리카 혈뇨증 치료 시장 세분화
기준 치료
- 약물
- 치료법
- 기타
표시별 span>
- 요로 감염
- 신장 결석
- 요도염
- 혈액암
- 방광결석
- 전립선암
- 방광염
- 외상
- 격렬함 운동
- 다낭성 신장 질환
- 자궁내막증
- 월경 span>
유형별
- 육안적 혈뇨
- 현미경적 혈뇨
- 특발성 혈뇨
- 조깅하는 사람의 혈뇨
최종 사용자에 의한
- 병원
- 클리닉
- 외래 수술 센터(ASC)
- 기타
국가별
- 중동 및amp; 아프리카
- UAE
- 사우디아라비아
- 남아프리카공화국
- 중동 및 기타 지역 아프리카
언급된 회사
< ul>TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Middle East & Africa Hematuria Treatment Market – By Treatment
1.3.2 Middle East & Africa Hematuria Treatment Market – By Indication
1.3.3 Middle East & Africa Hematuria Treatment Market – By Type
1.3.4 Middle East & Africa Hematuria Treatment Market – By End User
1.3.5 Middle East & Africa Hematuria Treatment Market – By Country
2. Middle East & Africa Hematuria Treatment Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Hematuria Treatment Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Middle East & Africa – PEST Analysis
4.3 Experts Opinion
5. Hematuria Treatment Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 High Prevalence of Hematuria-Associated Indications
5.1.2 Increasing Awareness About Treatment Options and Improving Healthcare Expenditure
5.2 Market Restraints
5.2.1 Undiagnosed Cases of Associated Indications
5.3 Market Opportunities
5.3.1 Increasing Opportunities for Related Treatments
5.4 Future Trends
5.4.1 Rise in Preference for Advanced Therapies
5.5 Impact Analysis
6. Hematuria Treatment Market – Middle East & Africa Analysis
6.1 Middle East & Africa Hematuria Treatment Market Revenue Forecast and Analysis
7. Hematuria Treatment Market Revenue and Forecast To 2028 – By Treatment
7.1 Overview
7.2 Middle East & Africa Hematuria Treatment Market Share by Treatment 2020 & 2028 (%)
7.3 Drugs
7.3.1 Overview
7.3.2 Drugs: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
7.4 Therapies
7.4.1 Overview
7.4.2 Therapies: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
7.5 Others
7.5.1 Overview
7.5.2 Others: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
8. Hematuria Treatment Market Revenue and Forecast To 2028 – By Indication
8.1 Overview
8.2 Middle East & Africa Hematuria Treatment Market Share by Indication 2020 & 2028 (%)
8.3 Kidney Stones
8.3.1 Overview
8.3.2 Kidney Stones: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
8.4 Urinary Tract Infections (UTI)
8.4.1 Overview
8.4.2 Urinary Tract Infections: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
8.5 Urethritis
8.5.1 Overview
8.5.2 Urethritis: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
8.6 Blood Cancer
8.6.1 Overview
8.6.2 Blood Cancer: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
8.7 Bladder Stones
8.7.1 Overview
8.7.2 Bladder Stones: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
8.8 Prostate Cancer
8.8.1 Overview
8.8.2 Prostate Cancer: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
8.9 Cystitis
8.9.1 Overview
8.9.2 Cystitis: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
8.10 Trauma
8.10.1 Overview
8.10.2 Trauma: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
8.11 Vigorous Exercise
8.11.1 Overview
8.11.2 Vigorous Exercise: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
8.12 Polycystic Kidney Disease
8.12.1 Overview
8.12.2 Polycystic Kidney Disease: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
8.13 Endometriosis
8.13.1 Overview
8.13.2 Endometriosis: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
8.14 Menstruation
8.14.1 Overview
8.14.2 Menstruation: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
9. Hematuria Treatment Market Revenue and Forecast To 2028 – By Type
9.1 Overview
9.2 Middle East & Africa Hematuria Treatment Market, By Type 2020 & 2028 (%)
9.3 Macroscopic Hematuria
9.3.1 Overview
9.3.2 Macroscopic Hematuria: Hematuria Treatment Market Revenue and Forecast to 2028(US$ Mn)
9.4 Microscopic Hematuria
9.4.1 Overview
9.4.2 Microscopic Hematuria: Hematuria Treatment Market Revenue and Forecast to 2028(US$ Mn)
9.5 Idiopathic Hematuria
9.5.1 Overview
9.5.2 Idiopathic Hematuria: Hematuria Treatment Market Revenue and Forecast to 2028(US$ Mn)
9.6 Jogger’s Hematuria
9.6.1 Overview
9.6.2 Jogger’s Hematuria: Hematuria Treatment Market Revenue and Forecast to 2028(US$ Mn)
10. Hematuria Treatment Market Revenue and Forecast To 2028 – By End User
10.1 Overview
10.2 Middle East & Africa Hematuria Treatment Market Share by End User 2020 & 2028 (%)
10.3 Hospitals
10.3.1 Overview
10.3.2 Hospitals: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
10.4 Clinics
10.4.1 Overview
10.4.2 Clinics: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
10.5 Ambulatory Surgical Centers (ASC’s)
10.5.1 Overview
10.5.2 Ambulatory Surgical Centers: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
10.6 Others
10.6.1 Overview
10.6.2 Others: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
11. Middle East & Africa Hematuria Treatment Market – Geographic Analysis
11.1 Middle East & Africa: Hematuria Treatment Market
11.1.1 Middle East & Africa: Hematuria Treatment Market– Revenue and Forecast to 2028 (USD Million)
11.1.2 Middle East & Africa: Hematuria Treatment Market, by Treatment- Revenue and Forecast to 2028 (USD Million)
11.1.3 Middle East & Africa: Hematuria Treatment Market, by Indication - Revenue and Forecast to 2028 (USD Million)
11.1.4 Middle East & Africa: Hematuria Treatment Market, by Type- Revenue and Forecast to 2028 (USD Million)
11.1.5 Middle East & Africa: Hematuria Treatment Market, by End User- Revenue and Forecast to 2028 (USD Million)
11.1.6 Middle East & Africa: Hematuria Treatment Market, by Country, 2021& 2028 (%)
11.1.6.1 Saudi Arabia: Hematuria Treatment Market– Revenue and Forecast to 2028 (USD Million)
11.1.6.1.1 Saudi Arabia: Hematuria Treatment Market– Revenue and Forecast to 2028 (USD Million)
11.1.6.1.2 Saudi Arabia: Hematuria Treatment Market, by Treatment- Revenue and Forecast to 2028 (USD Million)
11.1.6.1.3 Saudi Arabia: Hematuria Treatment Market, by Indication- Revenue and Forecast to 2028 (USD Million)
11.1.6.1.4 Saudi Arabia: Hematuria Treatment Market, by Type- Revenue and Forecast to 2028 (USD Million)
11.1.6.1.5 Saudi Arabia: Hematuria Treatment Market, by End User- Revenue and Forecast to 2028 (USD Million)
11.1.6.2 South Africa: Hematuria Treatment Market- Revenue and Forecast to 2028 (USD Million)
11.1.6.2.1 South Africa: Hematuria Treatment Market– Revenue and Forecast to 2028 (USD Million)
11.1.6.2.2 South Africa: Hematuria Treatment Market, by Treatment- Revenue and Forecast to 2028 (USD Million)
11.1.6.2.3 South Africa: Hematuria Treatment Market, by Indication- Revenue and Forecast to 2028 (USD Million)
11.1.6.2.4 South Africa: Hematuria Treatment Market, by Type- Revenue and Forecast to 2028 (USD Million)
11.1.6.2.5 South Africa: Hematuria Treatment Market, by End User- Revenue and Forecast to 2028 (USD Million)
11.1.6.3 UAE: Hematuria Treatment Market– Revenue and Forecast to 2028 (USD Million)
11.1.6.3.1 UAE: Hematuria Treatment Market– Revenue and Forecast to 2028 (USD Million)
11.1.6.3.2 UAE: Hematuria Treatment Market, by Treatment- Revenue and Forecast to 2028 (USD Million)
11.1.6.3.3 UAE: Hematuria Treatment Market, by Indication- Revenue and Forecast to 2028 (USD Million)
11.1.6.3.4 UAE: Hematuria Treatment Market, by Type - Revenue and Forecast to 2028 (USD Million)
11.1.6.3.5 UAE: Hematuria Treatment Market, by End User- Revenue and Forecast to 2028 (USD Million)
11.1.6.4 Rest of Middle East & Africa: Hematuria Treatment Market- Revenue and Forecast to 2028 (USD Million)
11.1.6.4.1 Rest of Middle East & Africa: Hematuria Treatment Market– Revenue and Forecast to 2028 (USD Million)
11.1.6.4.2 Rest of Middle East & Africa: Hematuria Treatment Market, by Treatment- Revenue and Forecast to 2028 (USD Million)
11.1.6.4.3 Rest of Middle East & Africa: Hematuria Treatment Market, by Indication- Revenue and Forecast to 2028 (USD Million)
11.1.6.4.4 Rest of Middle East & Africa: Hematuria Treatment Market, by Type- Revenue and Forecast to 2028 (USD Million)
11.1.6.4.5 Rest of Middle East & Africa: Hematuria Treatment Market, by End User- Revenue and Forecast to 2028 (USD Million)
12. Impact Of COVID-19 Pandemic on Hematuria Treatment Market
12.1 Middle East & Africa: Impact Assessment of COVID-19 Pandemic
13. Hematuria Treatment Market–Industry Landscape
13.1 Overview
13.2 Growth Strategies Done by the Companies in the Market, (%)
13.3 Organic Developments
13.3.1 Overview
13.4 Inorganic Developments
13.4.1 Overview
14. Company Profiles
14.1 AstraZeneca
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 Bristol-Myers Squibb Company
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 F. HOFFMANN-LA ROCHE LTD.
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.4 GlaxoSmithKline Plc
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments
14.5 Janssen Pharmaceuticals
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments
14.6 Merck & Co., Inc.
14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments
14.7 Novartis AG
14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments
14.8 Pfizer Inc.
14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments
14.9 Sun Pharmaceutical Industries Ltd
14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments
14.10 Boehringer Ingelheim International GmbH
14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Products and Services
14.10.4 Financial Overview
14.10.5 SWOT Analysis
14.10.6 Key Developments
15. Appendix
15.1 About The Insight Partners
15.2 Glossary of Terms
LIST OF TABLES
Table 1. Middle East & Africa Hematuria Treatment Market, by Treatment – Revenue and Forecast to 2028 (USD Million)
Table 2. Middle East & Africa Hematuria Treatment Market, by Indication – Revenue and Forecast to 2028 (USD Million)
Table 3. Middle East & Africa Hematuria Treatment Market, by Type– Revenue and Forecast to 2028 (USD Million)
Table 4. Middle East & Africa Hematuria Treatment Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 5. Saudi Arabia Hematuria Treatment Market, by Treatment – Revenue and Forecast to 2028 (USD Million)
Table 6. Saudi Arabia Hematuria Treatment Market, by Indication – Revenue and Forecast to 2028 (USD Million)
Table 7. Saudi Arabia Hematuria Treatment Market, by Type– Revenue and Forecast to 2028 (USD Million)
Table 8. Saudi Arabia Hematuria Treatment Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 9. South Africa Hematuria Treatment Market, by Treatment – Revenue and Forecast to 2028 (USD Million)
Table 10. South Africa Hematuria Treatment Market, by Indication – Revenue and Forecast to 2028 (USD Million)
Table 11. South Africa Hematuria Treatment Market, by Type– Revenue and Forecast to 2028 (USD Million)
Table 12. South Africa Hematuria Treatment Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 13. UAE Hematuria Treatment Market, by Treatment – Revenue and Forecast to 2028 (USD Million)
Table 14. UAE Hematuria Treatment Market, by Indication – Revenue and Forecast to 2028 (USD Million)
Table 15. UAE Hematuria Treatment Market, by Type– Revenue and Forecast to 2028 (USD Million)
Table 16. UAE Hematuria Treatment Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 17. Rest of Middle East & Africa Hematuria Treatment Market, by Treatment – Revenue and Forecast to 2028 (USD Million)
Table 18. Rest of Middle East & Africa Hematuria Treatment Market, by Indication – Revenue and Forecast to 2028 (USD Million)
Table 19. Rest of Middle East & Africa Hematuria Treatment Market, by Type– Revenue and Forecast to 2028 (USD Million)
Table 20. Rest of Middle East & Africa Hematuria Treatment Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 21. Organic Developments Done by Companies
Table 22. Inorganic Developments Done by Companies
Table 23. Glossary of Terms, Hematuria Treatment Market
LIST OF FIGURES
Figure 1. Hematuria Treatment Market Segmentation
Figure 2. Middle East & Africa Hematuria Treatment Market Overview
Figure 3. Macroscopic Hematuria Segment Held the Largest Share of the Type Segment in Hematuria Treatment Market
Figure 4. UAE to Show Significant Growth During Forecast Period
Figure 5. Middle East & Africa Hematuria Treatment Market, Industry Landscape
Figure 6. Middle East & Africa PEST Analysis
Figure 7. Hematuria Treatment Market Impact Analysis of Drivers and Restraints
Figure 8. Middle East & Africa Hematuria Treatment Market – Revenue Forecast and Analysis – 2020- 2028
Figure 9. Middle East & Africa Hematuria Treatment Market Share by Treatment 2020 & 2028 (%)
Figure 10. Drugs: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 11. Therapies: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 12. Others: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 13. Middle East & Africa Hematuria Treatment Market Share by Indication 2020 & 2028 (%)
Figure 14. Kidney Stones: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 15. Urinary Tract Infections: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 16. Urethritis: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 17. Blood Cancer: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 18. Bladder Stones: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 19. Prostate Cancer: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 20. Cystitis: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 21. Trauma: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 22. Vigorous Exercise: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 23. Polycystic Kidney Disease: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 24. Endometriosis: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 25. Menstruation: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 26. Middle East & Africa Hematuria Treatment Market, by Type 2020 & 2028 (%)
Figure 27. Macroscopic Hematuria: Hematuria Treatment Market Revenue and Forecast to 2028(US$ Mn)
Figure 28. Microscopic Hematuria: Hematuria Treatment Market Revenue and Forecast to 2028(US$ Mn)
Figure 29. Idiopathic Hematuria: Hematuria Treatment Market Revenue and Forecast to 2028(US$ Mn)
Figure 30. Jogger’s Hematuria: Hematuria Treatment Market Revenue and Forecast to 2028(US$ Mn)
Figure 31. Middle East & Africa Hematuria Treatment Market Share by End User 2020 & 2028 (%)
Figure 32. Hospitals: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 33. Clinics: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 34. Ambulatory Surgical Centers: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 35. Others: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 36. Middle East & Africa: Hematuria Treatment Market, by Key Country – Revenue (2021) (USD Million)
Figure 37. Middle East & Africa Hematuria Treatment Market Revenue and Forecast to 2028 (USD Million)
Figure 38. Middle East & Africa: Hematuria Treatment Market, by Country, 2021& 2028 (%)
Figure 39. Saudi Arabia: Hematuria Treatment Market– Revenue and Forecast to 2028 (USD Million)
Figure 40. South Africa: Hematuria Treatment Market– Revenue and Forecast to 2028 (USD Million)
Figure 41. UAE: Hematuria Treatment Market– Revenue and Forecast to 2028 (USD Million)
Figure 42. Rest of Middle East & Africa: Hematuria Treatment Market– Revenue and Forecast to 2028 (USD Million)
Figure 43. Impact Of COVID-19 Pandemic in Middle East & Africa Country Markets
Figure 44. Growth Strategies Done by the Companies in the Market, (%)
- AstraZeneca
- Bristol-Myers Squibb Company
- F. HOFFMANN-LA ROCHE LTD.
- GlaxoSmithKline plc.
- Janssen Pharmaceuticals
- Merck & Co., Inc.
- Novartis AG
- Pfizer Inc.
- Sun Pharmaceutical Industries Ltd
- Boehringer Ingelheim International GmbH
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Middle East & Africa hematuria treatment market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the Middle East & Africa hematuria treatment market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.